Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation

Remi A. Nout, Tjalling Bosse, Carien L. Creutzberg, Ina M. Jurgenliemk-Schulz, Jan J. Jobsen, Ludy C. H. W. Lutgens, Elzbieta M. van der Steen-Banasik, Ronald van Eijk, Natalja T. ter Haar, Vincent T. H. B. M. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)466-473
JournalGynecologic Oncology
Volume126
Issue number3
DOIs
Publication statusPublished - Sep 2012

Keywords

  • Endometrial cancer
  • Oncogenic pathway alterations
  • PI3K-AKT pathway
  • Wnt signaling pathway
  • Microsatellite-instability
  • P53 mutation

Cite this

Nout, R. A., Bosse, T., Creutzberg, C. L., Jurgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., van Eijk, R., ter Haar, N. T., & Smit, V. T. H. B. M. (2012). Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/beta-catenin and P53 pathway activation. Gynecologic Oncology, 126(3), 466-473. https://doi.org/10.1016/j.ygyno.2012.05.012